Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents

Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents

Glioblastoma (GBM) is the most aggressive adult brain tumour with a dismal 2-year survival rate of 26–33%. Maximal safe resection plays a crucial role in improving patient progression-free survival (PFS). Neurosurgeons have the significant challenge of delineating normal tissue from brain tumour to...

Full description

Bibliographic Details
Main Authors: Oluwakanyinsolami Netufo, Kate Connor, Liam P. Shiels, Kieron J. Sweeney, Dan Wu, Donal F. O’Shea, Annette T. Byrne, Ian S. Miller
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pharmaceuticals
Subjects:
glioblastoma
fluorescence guided surgery
5-ALA
fluorescein
NIR-AZA
Online Access:https://www.mdpi.com/1424-8247/15/5/550

Internet

https://www.mdpi.com/1424-8247/15/5/550

Similar Items